Publication | Closed Access

Effects of Rosiglitazone Alone and in Combination With Atorvastatin on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus

Metabolic SyndromeCardiovascular DiseaseMedicineDiabetesCardiovascular PharmacologyType 2HyperlipidemiaVascular BiologyPharmacotherapyDiabetes MellitusPharmacologyDyslipidemia